﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Academy of Medical Sciences of I.R. Iran</PublisherName>
      <JournalTitle>Archives of Iranian Medicine</JournalTitle>
      <Issn>1029-2977</Issn>
      <Volume>14</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2011</Year>
        <Month>03</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Hemiparkinsonism-Hemiatrophy Syndrome</ArticleTitle>
    <FirstPage>0</FirstPage>
    <LastPage>0</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Hormoz</FirstName>
        <LastName>Ayromlou</LastName>
      </Author>
      <Author>
        <FirstName>Safa</FirstName>
        <LastName>Najmi</LastName>
      </Author>
      <Author>
        <FirstName>Mohammad Ali</FirstName>
        <LastName>Arami</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
    </History>
    <Abstract>The syndrome of hemiparkinsonism-hemiatrophy is an uncommon form of secondary Parkinsonism that presents with unilateral body Parkinsonism plus variable atrophy on the same side. Diagnosis of this syndrome needs a complete past medical history taking, as well as assessment of the familial history, clinical examination and complete paraclinical tests.The response to medical therapy has been variable in various researchesThis case showed a good response to the addition of a dopamine agonist to levodopa therapy.</Abstract>
  </Article>
</ArticleSet>